140 related articles for article (PubMed ID: 20170099)
21. Epiminocyclohepta[b]indole analogs as 5-HT6 antagonists.
Henderson AJ; Guzzo PR; Ghosh A; Kaur J; Koo JM; Nacro K; Panduga S; Pathak R; Shimpukade B; Tan V; Xiang K; Wierschke JD; Isherwood ML
Bioorg Med Chem Lett; 2012 Feb; 22(4):1494-8. PubMed ID: 22290076
[TBL] [Abstract][Full Text] [Related]
22. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
[TBL] [Abstract][Full Text] [Related]
23. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.
de la Fuente T; Martín-Fontecha M; Sallander J; Benhamú B; Campillo M; Medina RA; Pellissier LP; Claeysen S; Dumuis A; Pardo L; López-Rodríguez ML
J Med Chem; 2010 Feb; 53(3):1357-69. PubMed ID: 20078106
[TBL] [Abstract][Full Text] [Related]
24. Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists.
Liu KG; Robichaud AJ; Greenfield AA; Lo JR; Grosanu C; Mattes JF; Cai Y; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Comery TA
Bioorg Med Chem; 2011 Jan; 19(1):650-62. PubMed ID: 21093272
[TBL] [Abstract][Full Text] [Related]
25. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
26. 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.
Ivachtchenko AV; Mitkin OD; Tkachenko SE; Okun IM; Kysil VM
Eur J Med Chem; 2010 Feb; 45(2):782-9. PubMed ID: 19939513
[TBL] [Abstract][Full Text] [Related]
27. 1,2,3,4-tetrahydrocarbazoles as 5-HT6 serotonin receptor ligands.
Chang-Fong J; Rangisetty JB; Dukat M; Setola V; Raffay T; Roth B; Glennon RA
Bioorg Med Chem Lett; 2004 Apr; 14(8):1961-4. PubMed ID: 15050637
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT₂B and 5-HT₇ receptor antagonists. Part 2.
Moritomo A; Yamada H; Watanabe T; Itahana H; Koga Y; Akuzawa S; Okada M
Bioorg Med Chem; 2014 Aug; 22(15):4323-37. PubMed ID: 24916029
[TBL] [Abstract][Full Text] [Related]
29. N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT₆ receptor antagonists.
Nirogi RV; Konda JB; Kambhampati R; Shinde A; Bandyala TR; Gudla P; Kandukuri KK; Jayarajan P; Kandikere V; Dubey PK
Bioorg Med Chem Lett; 2012 Nov; 22(22):6980-5. PubMed ID: 23036955
[TBL] [Abstract][Full Text] [Related]
30. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
Zhao SH; Berger J; Clark RD; Sethofer SG; Krauss NE; Brothers JM; Martin RS; Misner DL; Schwab D; Alexandrova L
Bioorg Med Chem Lett; 2007 Jun; 17(12):3504-7. PubMed ID: 17485206
[TBL] [Abstract][Full Text] [Related]
31. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.
Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Mitkin OD; Tkachenko SE; Kysil VM; Okun I
Eur J Med Chem; 2011 Apr; 46(4):1189-97. PubMed ID: 21333408
[TBL] [Abstract][Full Text] [Related]
32. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
Ahmed M; Briggs MA; Bromidge SM; Buck T; Campbell L; Deeks NJ; Garner A; Gordon L; Hamprecht DW; Holland V; Johnson CN; Medhurst AD; Mitchell DJ; Moss SF; Powles J; Seal JT; Stean TO; Stemp G; Thompson M; Trail B; Upton N; Winborn K; Witty DR
Bioorg Med Chem Lett; 2005 Nov; 15(21):4867-71. PubMed ID: 16143522
[TBL] [Abstract][Full Text] [Related]
33. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
[TBL] [Abstract][Full Text] [Related]
34. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
[TBL] [Abstract][Full Text] [Related]
35. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.
Riemer C; Borroni E; Levet-Trafit B; Martin JR; Poli S; Porter RH; Bös M
J Med Chem; 2003 Mar; 46(7):1273-6. PubMed ID: 12646038
[TBL] [Abstract][Full Text] [Related]
36. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
[TBL] [Abstract][Full Text] [Related]
37. Novel quinazolinone derivatives as 5-HT7 receptor ligands.
Na YH; Hong SH; Lee JH; Park WK; Baek DJ; Koh HY; Cho YS; Choo H; Pae AN
Bioorg Med Chem; 2008 Mar; 16(5):2570-8. PubMed ID: 18083580
[TBL] [Abstract][Full Text] [Related]
38. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
Hayat F; Cho S; Rhim H; Indu Viswanath AN; Pae AN; Lee JY; Choo DJ; Choo HY
Bioorg Med Chem; 2013 Sep; 21(17):5573-82. PubMed ID: 23810425
[TBL] [Abstract][Full Text] [Related]
40. Derivatives of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: synthesis and interactions with 5-HT1A receptors.
Höök BB; Cortizo L; Johansson AM; Westlind-Danielsson A; Mohell N; Hacksell U
J Med Chem; 1996 Sep; 39(20):4036-43. PubMed ID: 8831769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]